Trials / Unknown
UnknownNCT01498055
Autologous CIK Cells Infusion for the Treatment of Lung Cancer: a Randomized Controlled Study
A Randomized Controlled Trail on the Efficacy and Safety of Autologous Cytokine-induced Killer (CIK) Cells Infusion Treatment in Advanced Primary Lung Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Third Military Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To study the efficacy and safety of autologous CIK cells infusion for the treatment of lung cancer.
Detailed description
A randomized controlled trail on the efficacy and safety of autologous cytokine-induced killer (CIK) cells infusion treatment in advanced primary lung cancer
Conditions
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2011-12-23
- Last updated
- 2012-03-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01498055. Inclusion in this directory is not an endorsement.